Andzonbio1’s website
Paris, FR · 1 known investors
Andzon Bio develops breakthrough therapeutic programs targeting core disease mechanisms of underserved cardiovascular, renal, and metabolic (CVRM) conditions. It sources and derisks programs from Europe's academic research centers and advances them toward clinical development.